Sfoglia per AUTORE
ORTEGA C
Collezione AOU Novara

  

Items : 7

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group? in European urology oncology / Eur Urol Oncol. 2024 Feb;7(1):102-111. doi: 10.1016/j.euo.2023.07.003. Epub 2023 Jul 21.

2024
ASL Cuneo 2
AOU Novara

Porta C; Battelli N; Bracarda S; Sorgentoni G; Monteiro FSM; Mollica V; Rizzo A; Zabalza IO; Bimbatti D; Soares A; Bisonni R; Rebuzzi SE; Roviello G; Incorvaia L; Morelli F; Santini D; Vau N; Bhuva D; Küronya Z; Mosca A; Landmesser J; Milella M; Messina C; Bassanelli M; Ortega C; Grillone F; Procopio G; Sunela K; Caffo O; et alii...

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2023 Nov;72(11):3665-3682. doi: 10.1007/s00262-023-03518-z. Epub 2023 Sep

2023
ASL Cuneo 2
AOU Novara

Santoni M; Porta C; Bellmunt J; Battelli N; Sorgentoni G; Landmesser J; Rizzo A; Mollica V; Zabalza IO; Zgura A; Incorvaia L; Ansari J; Pinto A; Soares A; Nunes F; Maluf F; Morelli F; Mosca A; Zakopoulou R; Bisonni R; Manneh R; Santini D; Inman E; Herchenhorn D; Kanesvaran R; Caitano M; Milella M; Kopecky J; Martignetti A; et alii...

Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Aug;75(4):460-470. doi: 10.23736/S2724-6051.23.05369-7.

2023
AO Cuneo
ASL Cuneo 2
AOU Novara

Grande E; Santoni M; Buti S; Battelli N; Sorgentoni G; Pierantoni F; Monteiro FS; Rebuzzi SE; Roviello G; Soares A; Zabalza IO; Rizzo A; Bisonni R; Morelli F; Incorvaia L; Küronya Z; Mosca A; Bhuva D; Santini D; Vau N; Messina C; Merler S; Landmesser J; Grillone F; Ortega C; Sunela K; Ansari J; Atzori F; Bassanelli M; et alii...

Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Sep;155:127-135. doi: 10.1016/j.ejca.2021.06.034. Epub 2021 Aug 6.

2021
AO Cuneo
ASL Asti
ASL Biella
ASL Cuneo 2
AOU Città della Salute di Torino
ASL Città di Torino
AOU Novara

Tucci M; Berruti A; Bianchi S; Ciccone G; Baier S; Gennari A; Amoroso D; Montagnani F; Comandone A; Bellissimo AR; Sacco C; Fea E; Vanella P; Valcamonico F; Zamparini M; Sirotova Z; Chiappino I; Dal Canton O; Masini C; Dalla Volta A; Prati V; Ortega C; Buttigliero C; Mosca A;

Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma. in The Journal of urology / J Urol. 2015 Jun;193(6):1905-10. doi: 10.1016/j.juro.2014.11.092. Epub 2014 Nov 26.

2015
AOU Novara

Iacovelli R; Farcomeni A; Sternberg CN; Cartenì G; Milella M; Santoni M; Cerbone L; Di Lorenzo G; Verzoni E; Ortega C; Sabbatini R; Ricotta R; Messina C; Lorusso V; Atzori F; De Vincenzo F; Sacco C; Boccardo F; Valduga F; Massari F; Baldazzi V; Cinieri S; Mosca A; Maria Ruggeri E; Berruti A; Procopio G;

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma. in The Journal of urology / J Urol. 2015 Jan;193(1):41-7. doi: 10.1016/j.juro.2014.07.011. Epub 2014 Jul 18.

2015
AOU Novara

Santoni M; Conti A; Porta C; Procopio G; Sternberg CN; Basso U; De Giorgi U; Bracarda S; Rizzo M; Ortega C; Massari F; Iacovelli R; Derosa L; Masini C; Milella M; Di Lorenzo G; Atzori F; Pagano M; Buti S; De Vivo R; Mosca A; Rossi M; Paglino C; Verzoni E; Cerbone L; Muzzonigro G; Falconi M; Montironi R; Burattini L; et alii...

Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2013 Jun;49(9):2134-42. doi: 10.1016/j.ejca.2013.02.032. Epub 2013 Mar 18.

2013
AOU Novara

Iacovelli R; Cartenì G; Sternberg CN; Milella M; Santoni M; Di Lorenzo G; Ortega C; Sabbatini R; Ricotta R; Messina C; Lorusso V; Atzori F; De Vincenzo F; Sacco C; Boccardo F; Valduga F; Massari F; Baldazzi V; Cinieri S; Mosca A; Ruggeri EM; Berruti A; Cerbone L; Procopio G;